Your browser doesn't support javascript.
loading
Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer.
Slavish, P Jake; Chi, Liying; Yun, Mi-Kyung; Tsurkan, Lyudmila; Martinez, Nancy E; Jonchere, Barbara; Chai, Sergio C; Connelly, Michele; Waddell, M Brett; Das, Sourav; Neale, Geoffrey; Li, Zhenmei; Shadrick, William R; Olsen, Rachelle R; Freeman, Kevin W; Low, Jonathan A; Price, Jeanine E; Young, Brandon M; Bharatham, Nagakumar; Boyd, Vincent A; Yang, Jun; Lee, Richard E; Morfouace, Marie; Roussel, Martine F; Chen, Taosheng; Savic, Daniel; Guy, R Kiplin; White, Stephen W; Shelat, Anang A; Potter, Philip M.
Afiliação
  • Slavish PJ; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Chi L; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Yun MK; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Tsurkan L; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Martinez NE; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Jonchere B; Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Chai SC; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Connelly M; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Waddell MB; Molecular Interaction Analysis Shared Resource, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Das S; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Neale G; Hartwell Center, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Li Z; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Shadrick WR; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Olsen RR; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Freeman KW; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Low JA; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Price JE; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Young BM; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Bharatham N; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Boyd VA; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Yang J; Department of Surgery, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Lee RE; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Morfouace M; Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Roussel MF; Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Chen T; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Savic D; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Guy RK; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • White SW; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Shelat AA; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee. phil.potter@stjude.org anang.shelat@stjude.org.
  • Potter PM; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee. phil.potter@stjude.org anang.shelat@stjude.org.
Cancer Res ; 80(17): 3507-3518, 2020 09 01.
Article em En | MEDLINE | ID: mdl-32651255
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Desenho de Fármacos / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Child / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Desenho de Fármacos / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Child / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article